|
Volumn 63, Issue 3, 2004, Pages 596-601
|
Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BACTERIAL ANTIGEN;
BACTERIAL DNA;
BCG VACCINE;
CYTOKINE;
INTERLEUKIN 12;
RECOMBINANT PROTEIN;
SYNTHETIC DNA;
ACTIVE IMMUNIZATION;
ANIMAL;
ARTICLE;
BAGG ALBINO MOUSE;
BLADDER TUMOR;
C3H MOUSE;
DRUG SCREENING;
ELECTROPORATION;
FEMALE;
GENE THERAPY;
GENE VECTOR;
GENETICS;
GERMFREE ANIMAL;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
ISOGRAFT;
MOUSE;
MULTIMODALITY CANCER THERAPY;
MYCOBACTERIUM BOVIS;
NUDE MOUSE;
SECRETION;
TH1 CELL;
TRANSITIONAL CELL CARCINOMA;
TUMOR ASSOCIATED LEUKOCYTE;
ANIMALS;
ANTIGENS, BACTERIAL;
BCG VACCINE;
CARCINOMA, TRANSITIONAL CELL;
COMBINED MODALITY THERAPY;
CYTOKINES;
DNA, BACTERIAL;
ELECTROPORATION;
FEMALE;
GENE THERAPY;
GENES, SYNTHETIC;
GENETIC VECTORS;
HUMANS;
IMMUNOTHERAPY;
IMMUNOTHERAPY, ACTIVE;
INTERLEUKIN-12;
LYMPHOCYTES, TUMOR-INFILTRATING;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C3H;
MICE, NUDE;
MYCOBACTERIUM BOVIS;
RECOMBINANT PROTEINS;
SPECIFIC PATHOGEN-FREE ORGANISMS;
TH1 CELLS;
TRANSPLANTATION, ISOGENEIC;
URINARY BLADDER NEOPLASMS;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
MLCS;
MLOWN;
|
EID: 2942668152
PISSN: None
EISSN: 15279995
Source Type: Journal
DOI: 10.1016/j.urology.2003.09.039 Document Type: Article |
Times cited : (14)
|
References (0)
|